191 related articles for article (PubMed ID: 23935247)
1. Inhibitory effect of herbal remedy PERVIVO and anti-inflammatory drug sulindac on L-1 sarcoma tumor growth and tumor angiogenesis in Balb/c mice.
Skopiński P; Bałan BJ; Kocik J; Zdanowski R; Lewicki S; Niemcewicz M; Gawrychowski K; Skopińska-Różewska E; Stankiewicz W
Mediators Inflamm; 2013; 2013():289789. PubMed ID: 23935247
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Activity for Natural and Synthetic Inhibitors of Angiogenesis Induced by Murine Sarcoma L-1 and Human Kidney Cancer Cells.
Bałan BJ; Siwicki AK; Pastewka K; Demkow U; Skopiński P; Skopińska-Różewska E; Lewicki S; Zdanowski R
Adv Exp Med Biol; 2017; 1020():91-104. PubMed ID: 28456932
[TBL] [Abstract][Full Text] [Related]
3. Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone.
Skopinski P; Szaflik J; Duda-Król B; Nartowska J; Sommer E; Chorostowska-Wynimko J; Demkow U; Skopinska-Rózewska E
Int J Mol Med; 2004 Oct; 14(4):707-11. PubMed ID: 15375605
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic and apoptotic effects of metabolites of sulindac on chick embryo chorioallantoic membrane.
Elwich-Flis S; Sołtysiak-Pawluczuk D; Spławiński J
Hybrid Hybridomics; 2003 Feb; 22(1):55-60. PubMed ID: 12713691
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of Greenland shark liver oil combined with squalen and arctic birch ashes on angiogenesis and L-1 sarcoma growth in Balb/c mice.
Skopińska-Rózewska E; Chorostowska-Wynimko J; Krotkiewski M; Rogala E; Sommer E; Demkow U; Skurzak H
Pol J Vet Sci; 2003; 6(3 Suppl):54-6. PubMed ID: 14509365
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis by sulindac and its sulfone metabolite (FGN-1): a potential mechanism for their antineoplastic properties.
Skopińska-Rózewska E; Piazza GA; Sommer E; Pamukcu R; Barcz E; Filewska M; Kupis W; Caban R; Rudziński P; Bogdan J; Mlekodaj S; Sikorska E
Int J Tissue React; 1998; 20(3):85-9. PubMed ID: 9894180
[TBL] [Abstract][Full Text] [Related]
7. Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.
Wong CC; Cheng KW; Xie G; Zhou D; Zhu CH; Constantinides PP; Rigas B
J Pharmacol Exp Ther; 2012 Feb; 340(2):422-32. PubMed ID: 22085648
[TBL] [Abstract][Full Text] [Related]
8. NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.
Zhou H; Liu W; Su Y; Wei Z; Liu J; Kolluri SK; Wu H; Cao Y; Chen J; Wu Y; Yan T; Cao X; Gao W; Molotkov A; Jiang F; Li WG; Lin B; Zhang HP; Yu J; Luo SP; Zeng JZ; Duester G; Huang PQ; Zhang XK
Cancer Cell; 2010 Jun; 17(6):560-73. PubMed ID: 20541701
[TBL] [Abstract][Full Text] [Related]
9. Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator.
Yin T; Wang G; Ye T; Wang Y
Sci Rep; 2016 Jan; 6():19534. PubMed ID: 26777116
[TBL] [Abstract][Full Text] [Related]
10. Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice.
Yasui H; Adachi M; Imai K
Cancer; 2003 Mar; 97(6):1412-20. PubMed ID: 12627504
[TBL] [Abstract][Full Text] [Related]
11. The effect of pentoxifylline on L-1 sarcoma tumor growth and angiogenesis in Balb/c mice.
Bałan BJ; Demkow U; Skopiński P; Bychawska M; Skopińska-Różewska E; Lewicki S; Zdanowski R
Cent Eur J Immunol; 2017; 42(2):131-139. PubMed ID: 28860931
[TBL] [Abstract][Full Text] [Related]
12. A quantitative angiogenesis model for efficacy testing of chemopreventive agents.
Sharma S; Ghoddoussi M; Gao P; Kelloff GJ; Steele VE; Kopelovich L
Anticancer Res; 2001; 21(6A):3829-37. PubMed ID: 11911254
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest.
Flis S; Soltysiak-Pawluczuk D; Jedrych A; Jastrzebski Z; Remiszewska M; Splawinski J
Anticancer Res; 2006; 26(4B):3033-41. PubMed ID: 16886631
[TBL] [Abstract][Full Text] [Related]
14. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
[TBL] [Abstract][Full Text] [Related]
15. Sulindac enhances the proteasome inhibitor bortezomib-mediated oxidative stress and anticancer activity.
Minami T; Adachi M; Kawamura R; Zhang Y; Shinomura Y; Imai K
Clin Cancer Res; 2005 Jul; 11(14):5248-56. PubMed ID: 16033843
[TBL] [Abstract][Full Text] [Related]
16. Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Orner GA; Dashwood WM; Blum CA; Díaz GD; Li Q; Al-Fageeh M; Tebbutt N; Heath JK; Ernst M; Dashwood RH
Mutat Res; 2002 Sep; 506-507():121-7. PubMed ID: 12351151
[TBL] [Abstract][Full Text] [Related]
17. Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits.
Verheul HM; Panigrahy D; Yuan J; D'Amato RJ
Br J Cancer; 1999 Jan; 79(1):114-8. PubMed ID: 10408702
[TBL] [Abstract][Full Text] [Related]
18. Sulindac modulates secreted protein expression from LIM1215 colon carcinoma cells prior to apoptosis.
Greening DW; Ji H; Kapp EA; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2293-307. PubMed ID: 23899461
[TBL] [Abstract][Full Text] [Related]
19. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling.
Vaish V; Sanyal SN
Biomed Pharmacother; 2012 Jul; 66(5):354-67. PubMed ID: 22397759
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells.
Fogli S; Banti I; Stefanelli F; Picchianti L; Digiacomo M; Macchia M; Breschi MC; Lapucci A
Eur J Med Chem; 2010 Nov; 45(11):5100-7. PubMed ID: 20801552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
